Martin Anthony Gleeson

This inventor holds 18 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 7 EPO patents, primarily in Nucleic Acid Synthesis. Top assignees: Life Technologies Corporation, Cognis Corporation, Sibia Neurosciences, Inc.. Active years: 1993-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martin Anthony Gleeson. Retrieved from https://idiyas.com/inventor/martin-anthony-gleeson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 18 (Patent Applications = 4)

% Patents Active = 72.2

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 7 (Patent Applications = 3)

Average Co-Inventor Count = 4.3

ph-index = 6

Forward Citations = 103(Granted Patents)

Company Filing History:

4 out of 1,896

Life Technologies Corporation

Sibia Neurosciences, Inc.

patents

4. 2 out of 143

Invitrogen Corporation

patents

5. 2 out of 25

The Salk Institute Biotechnology Industrial Associates, Inc.

Henkel Research Corporation

University of Illinois

patents

10. 1 out of 834,601

Other

patents

where one patent can have more than one assignee

Years Active: 1993-2018

Loading Chart...

Areas of Expertise:

Optical Analyte Detection

Nucleic Acid Synthesis

Recombinant Molecules

Pichia Proteolytic Activity

Cytochrome P450

Insulin-like Growth Factor-1

Transformation System

Recognition Sites

Methylotrophic Yeast

Methods of Use

Compositions

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9921165 - Optical analyte detection systems and methods of use (2018-03-20),

2. 9309520 - Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites (2016-04-12),

3. 8945884 - Methods and compositions for synthesis of nucleic acid molecules using multiplerecognition sites (2015-02-03),

4. 8207318 - Methods and compositions for generating recombinant nucleic acid molecules (2012-06-26),

5. 8030066 - Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites (2011-10-04),

6. 7244560 - Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites (2007-07-17),

7. 7109009 - [object Object] (2006-09-19),

8. 7063972 - [object Object] (2006-06-20),

9. 7049112 - [object Object] (2006-05-23),

10. 7033801 - Compositions and methods for rapidly generating recombinant nucleic acid molecules (2006-04-25),

11. 6331420 - Cytochrome P450 monooxygenase and NADPH cytochrome P450 oxidoreductase genes and proteins related to the omega hydroxylase complex of Candida tropicalis and methods relating thereto (2001-12-18),

12. 6051419 - Genes which influence pichia proteolytic activity, and uses therefor (2000-04-18),

13. 5831053 - Genes which influence pichia proteolytic activity, and uses therefor (1998-11-03),

14. 5691166 - Genes which influence pichia proteolytic activity, and uses therefor (1997-11-25),

15. 5612198 - Production of insulin-like growth factor-1 in methylotrophic yeast cells (1997-03-18),

Title: The Innovative Journey of Martin Anthony Gleeson

Introduction: Martin Anthony Gleeson is a visionary inventor based in San Diego, CA, known for his groundbreaking contributions to various fields.

Latest Patents: Martin Anthony Gleeson holds several patents in the areas of renewable energy technologies, medical devices, and artificial intelligence systems.

Career Highlights: With a career spanning over two decades, Gleeson has been at the forefront of innovation, leading research teams and developing cutting-edge solutions that have revolutionized industries.

Collaborations: Throughout his career, Martin Anthony Gleeson has collaborated with top research institutions, leading companies, and brilliant minds to bring his ideas to life and make a lasting impact on society.

Conclusion: Martin Anthony Gleeson's passion for innovation and his relentless drive to push the boundaries of what is possible make him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.